Skip to main content
. 2019 Oct 8;50(1):12–21. doi: 10.4070/kcj.2019.0288

Figure 1. Efficacy of autologous BM-MNCs implantation in patients with CLI. Kaplan-Meier analysis of overall survival, major amputation-free, and total amputation-free survival following BM-MNC implantation in patients with PAD (ASO), TAO, and CDV.40).

Figure 1

ASO = arteriosclerosis obliterans; BM-MNC = bone marrow mononuclear cell; CDV = collagen disease-associated vasculitis; CLI = critical limb ischemia; PAD = peripheral artery disease; TAO = thromboangiitis obliterans.